Institution scientifique

Arrakis Therapeutics (United States)

Waltham, US, company

64Publications signalées

1394Citations signalées

12Thèmes principaux

Les principaux domaines

RNA and protein synthesis mechanismsRNA modifications and cancerRNA Research and SplicingDNA and Nucleic Acid ChemistryCAR-T cell therapy researchAdvanced biosensing and bioanalysis techniquesMonoclonal and Polyclonal Antibodies ResearchProtein Degradation and InhibitorsLymphoma Diagnosis and TreatmentCRISPR and Genetic EngineeringRNA regulation and diseaseGenomics and Phylogenetic Studies

L’évolution annuelle

2017 1

2018 5

2019 1

2020 2

2021 3

2022 3

2023 8

2024 15

2025 15

2026 9

Les publications récentes

2026 conference-abstract OpenAlex

MPN-1206: Discovery and Characterization of DMR-001, an Fc-Null, Half-Life–Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Byron Kwan, Shannon Elf, Alexandra Grassian, Tyler Rouskin-Faust et autres

us (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

2026 article OpenAlex

POSTER: MPN-1206: Discovery and Characterization of DMR-001, an Fc-Null, Half-Life–Optimized Monoclonal Antibody Selectively Targeting Mutant Calreticulin

Byron Kwan, Shannon Elf, Alexandra Grassian, Tyler Rouskin-Faust et autres

us (code pays fourni par la source)

0 citations Clinical Lymphoma Myeloma & Leukemia

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: ProteinConformers: large-scale and energetically profiled descriptions of protein conformational landscapes

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: Rescuing the Function of Missense-Mutated Tumor Suppressor VHL using Stabilizing Small Molecules

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: Intracellular expression of a fluorogenic DNA aptamer using retron Eco2

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: In silico design and validation of high-affinity RNA aptamers for SARS-CoV-2 comparable to neutralizing antibodies

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 peer-review OpenAlex

eLife Assessment: Intracellular Expression of a Fluorogenic DNA Aptamer Using Retron Eco2

us (code pays fourni par la source)

0 citations

Accès ouvert 2026 article OpenAlex

Single Molecule Force Measurements Reveal Energy Stabilization of Theophylline Aptamer RNA Switch Required for Gene Control

Favian A. Liu, Brian A. Dawes, William J. Torg, Elena Menichelli et autres

us (code pays fourni par la source)

0 citations ACS Physical Chemistry Au

Accès ouvert 2025 preprint OpenAlex

Pharmacologic inhibition of BAF chromatin remodeling complexes as a therapeutic approach to transcription factor-dependent cancers

Richard C. Centore, Luis M. M. Soares, Salih Topal, Rishi G. Vaswani et autres

us, cn, ch, pk, gb, it, Nigéria (code pays fourni par la source)

1 citation eLife

2025 conference-abstract OpenAlex

Surovatamig (AZD0486), a CD19xCD3 T-cell engager (TCE), demonstrates high rate of minimal residual disease (MRD)–Negative complete responses in Relapsed/Refractory (R/R) diffuse large B-cell lymphoma (DLBCL), including in patients who previously progressed on CD20 TCE and CD19 CAR T-cell therapies

Tae‐Min Kim, Jing‐Zhou Hou, Sameh Gaballa, Ranjit Nair et autres

kr, us, jp, au, tw, gb (code pays fourni par la source)

3 citations Blood

Accès ouvert 2025 conference-abstract OpenAlex

Identification of novel, potent, and selective JAK2V617F inhibitors

Fazal Hadi, Peter Linders, Kimberly J. Ornell, April Chen et autres

nl, us, gb (code pays fourni par la source)

1 citation Blood

Site officiel Identifiant ROR

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.